What is Boston Scientific's exclusion from ebitda for restructuring charges?

Boston Scientific (BSX) reported exclusion from ebitda for restructuring charges of $500.00M in Q3 2025.

How has Boston Scientific's exclusion from ebitda for restructuring charges changed year-over-year?

Boston Scientific's exclusion from ebitda for restructuring charges decreased by 0.0% year-over-year, from $500.00M to $500.00M.

Other

Exclusion from EBITDA for Restructuring Charges

Boston Scientific Exclusion from EBITDA for Restructuring Charges remained flat by 0.0% to $500.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $500.00M to $500.00M.

Analysis

StatementBalance Sheet Statement

SectionOther

First reportedQ1 2019

Last reportedQ3 2025

Metric ID: other_exclusion_from_ebitda_for_restructuring_charges

Historical Data

14 periods

	Q2 '21	Q3 '21	Q1 '22	Q2 '22	Q3 '22	Q1 '23	Q2 '23	Q3 '23	Q1 '24	Q2 '24	Q3 '24	Q1 '25	Q2 '25	Q3 '25
Value	$500.00M	$500.00M	$500.00M	$500.00M	$500.00M	$500.00M	$500.00M	$500.00M	$500.00M	$500.00M	$500.00M	$500.00M	$500.00M	$500.00M
QoQ Change	—	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%
YoY Change	—	—	—	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%	+0.0%

Range$500.00M – $500.00M

CAGR+0.0%

Avg YoY Growth+0.0%

Median YoY Growth+0.0%

Current Streak13+ quarters growth

Frequently Asked Questions

What is Boston Scientific's exclusion from ebitda for restructuring charges?: Boston Scientific (BSX) reported exclusion from ebitda for restructuring charges of $500.00M in Q3 2025.
How has Boston Scientific's exclusion from ebitda for restructuring charges changed year-over-year?: Boston Scientific's exclusion from ebitda for restructuring charges decreased by 0.0% year-over-year, from $500.00M to $500.00M.